報價延遲最少15分鐘:2026/03/09 14:48 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
11.9799 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-37.80/-0.45
|
|
企業價值
8.21M
|
| 資產負債 |
|
每股賬面淨值
44.92
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
422.11K
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in asingle geographic location, the United States. |
